As director of corporate and commercial strategy, Tan developed, communicated and executed corporate and commercial strategic initiatives of the iX Group.
See also: Singtel’s Optus appoints non-executive director John Arthur as chairman of the board
According to iX Biopharma’s website, Tan was a corporate lawyer at Wong Partnership prior to joining iX Biopharma, where she specialised in the capital markets practice.
She was involved in numerous local and international IPOs, including the listing of iX Biopharma Ltd on the SGX Catalist in 2015.
She has also had extensive experience advising on a broad range of local and cross border mergers and acquisitions and other corporate transactions.
Shares of iX Biopharma closed at 26 cents on 18 Jan, 1 cent higher than the day before.
